Coralert
Coralert44About
What does Coralert do?
Coralert has developed an accurate, easy-to-use, non-invasive device for measuring Left Ventricular End-Diastolic Pressure (LVEDP) in real-time. Their device accurately estimates LVEDP along with other vital hemodynamic indices, providing physicians with a comprehensive hemodynamic profile to determine the exact type of cardiac condition.
What is Coralert's revenue?
StartupHub estimates Coralert's annual revenue at $716K (range $414K to $1.1M, 66% confidence), based on comparable companies in the sector.
What is Coralert's valuation?
StartupHub estimates Coralert's effective valuation at $3.1M (range $2.0M to $4.8M, 10% confidence), based on comparable companies in the sector.
How much funding has Coralert raised?
Coralert has raised a total of $800K in funding. The most recent round on record is Seed.
Where is Coralert headquartered?
Coralert is headquartered in Tel Aviv, Israel.
When was Coralert founded?
Coralert was founded in 2016.
What industry does Coralert operate in?
Coralert operates in Healthcare, Diagnostics, Heart Failure, MedTech, HealthTech, Medical Devices.
How many employees does Coralert have?
Coralert has approximately 4 people on record.
What is Coralert's current status?
Coralert's current operating status is: Inactive.
No comments yet. Be the first to share your take.